Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avid Bioservices (DE:TEHP)
FRANKFURT:TEHP
Holding DE:TEHP?
Track your performance easily
TEHP Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€4.12 - €11.70
Previous Close€11.7
Volume0.00
Average Volume (3M)2.00
Market Cap
€742.38M
Enterprise Value€910.40M
Total Cash (Recent Filing)$33.38M
Total Debt (Recent Filing)$205.96M
Price to Earnings (P/E)―
Beta0.30
Next Earnings
Dec 03, 2024EPS Estimate
-€0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding63,795,108
10 Day Avg. Volume0
30 Day Avg. Volume2
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)12.50
Price to Sales (P/S)5.46
Price to Cash Flow (P/CF)-52.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.40
Enterprise Value/Gross Profit124.41
Enterprise Value/Ebitda-78.56
Forecast
1Y Price Target
€11.87Price Target Upside1.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Avid Bioservices News
PremiumCompany Announcements
Avid Bioservices Reports Revenue Growth Amid Acquisition Plans
PremiumPre-Earnings
Is CDMO a Buy, Before Earnings?
PremiumCompany Announcements
Avid Bioservices to be Acquired in $1.1 Billion Deal
Options Prices
Currently, No data available
---
Ownership Overview
9.43% Insiders
16.68% Mutual Funds
45.28% Other Institutional Investors
14.50% Public Companies and
Individual Investors
TEHP FAQ
What was Avid Bioservices’s price range in the past 12 months?
Avid Bioservices lowest stock price was €4.12 and its highest was €11.70 in the past 12 months.
What is Avid Bioservices’s market cap?
Currently, no data Available
When is Avid Bioservices’s upcoming earnings report date?
Avid Bioservices’s upcoming earnings report date is Dec 03, 2024 which is 19 days ago.
How were Avid Bioservices’s earnings last quarter?
Avid Bioservices released its earnings results on Sep 09, 2024. The company reported -€0.086 earnings per share for the quarter, missing the consensus estimate of -€0.052 by -€0.033.
Is Avid Bioservices overvalued?
According to Wall Street analysts Avid Bioservices’s price is currently Undervalued.
Does Avid Bioservices pay dividends?
Avid Bioservices does not currently pay dividends.
What is Avid Bioservices’s EPS estimate?
Avid Bioservices’s EPS estimate is -€0.11.
How many shares outstanding does Avid Bioservices have?
Avid Bioservices has 63,955,784 shares outstanding.
What happened to Avid Bioservices’s price movement after its last earnings report?
Avid Bioservices reported an EPS of -€0.086 in its last earnings report, missing expectations of -€0.052. Following the earnings report the stock price went up 3.774%.
Which hedge fund is a major shareholder of Avid Bioservices?
Among the largest hedge funds holding Avid Bioservices’s share is Royce & Associates LLC. It holds Avid Bioservices’s shares valued at 9M.
---
Avid Bioservices Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€11.87 (1.46% Upside)
€11.87 (1.46% Upside)
Blogger Sentiment
Bullish
DE:TEHP Sentiment 100%
Sector Average 72%
Sector Average 72%
Technicals
SMA
Positive
20 days / 200 days
Momentum
141.73%
12-Months-Change
Fundamentals
Return on Equity
-115.84%
Trailing 12-Months
Asset Growth
-24.46%
Trailing 12-Months
Company Description
Avid Bioservices
Avid Bioservices, Inc. engages in the commercial manufacturing which focuses on biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. The firm specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions, and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.
---
TEHP Earnings Call
Q1 2024
0:00 / 0:00
---
TEHP Stock 12 Month Forecast
Average Price Target
€11.87
▲(1.46% Upside)
Technical Analysis
Avid Bioservices
―
Catalent
―
Lantheus
―
Pacira Pharmaceuticals
―
Amphastar Pharmaceuticals
―
Best Analysts Covering TEHP
1 Year
1 Year Success Rate
15/25 ratings generated profit
1 Year Average Return
+35.82%
assigned a buy rating 2 months ago
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +35.82% per trade.
---